Cargando…

Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways

Kangxian ruangan (KXRG) is a traditional Chinese medicine (TCM) formula consisting of 12 herbs. TCM syndrome differentiation proposes that KXRG exerts pharmacological effects against nonalcoholic fatty liver disease (NAFLD) fibrosis. This work investigates the effect of KXRG on NAFLD fibrosis in viv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Liming, Zhou, Ying, Dai, Dan, Xia, Hongmei, Zhao, Kang, Zhang, Jianjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371615/ https://www.ncbi.nlm.nih.gov/pubmed/34422075 http://dx.doi.org/10.1155/2021/5649575

Ejemplares similares

Antifibrotic effect of methylated quercetin derivatives on TGFβ-induced hepatic stellate cells
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Minimal Hepatic Encephalopathy and Biejia-Ruangan Are Associated with First Hospital Readmission in Nonalcoholic Cirrhosis Patients
por: Jiang, Ting-Ting, et al.
Publicado: (2021)

Network Pharmacology and Molecular Docking to Explore the Mechanism of Kangxian Decoction for Epilepsy
por: Wang, Weitao, et al.
Publicado: (2022)

Antifibrotic therapies to control cardiac fibrosis
por: Fan, Zhaobo, et al.
Publicado: (2016)

Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics
por: Shang, Xiaofei, et al.
Publicado: (2022)

Thunbergia laurifolia Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells
por: Namsen, Ratchadaporn, et al.
Publicado: (2017)

Hepatic Stellate Cells: Dictating Outcome in Nonalcoholic Fatty Liver Disease
por: Wiering, Leke, et al.
Publicado: (2023)

Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis
por: He, Lu, et al.
Publicado: (2020)

Ultrasonic-assisted extraction brings high-yield polysaccharides from Kangxian flowers with cosmetic potential
por: Zhang, Yang, et al.
Publicado: (2023)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study
por: El-Lakkany, Naglaa M., et al.
Publicado: (2018)

Hydralazine Sensitizes to the Antifibrotic Effect of 5-Aza-2′-deoxycytidine in Hepatic Stellate Cells
por: Asada, Kiyoshi, et al.
Publicado: (2020)

Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells
por: Wang, Yuan-Hsi, et al.
Publicado: (2020)

Diallyl trisulfide plays an antifibrotic role by inhibiting the expression of Bcl‐2 in hepatic stellate cells
por: Pang, Huai, et al.
Publicado: (2022)

Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling
por: Li, Meng, et al.
Publicado: (2017)

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
por: Ismail, Mona H, et al.
Publicado: (2011)

Efficacy and safety of Fufang Biejia Ruangan Tablets as an adjuvant treatment for chronic hepatitis B liver fibrosis: A systematic review and meta-analysis
por: Meng, Xiangbo, et al.
Publicado: (2022)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Regulation of Shaoyao Ruangan Mixture on Intestinal Flora in Mice With Primary Liver Cancer
por: Zhen, Hongde, et al.
Publicado: (2019)

Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl(4)-induced liver fibrosis
por: Shen, Baode, et al.
Publicado: (2021)

Lipoprotein Lipase Up‐regulation in Hepatic Stellate Cells Exacerbates Liver Fibrosis in Nonalcoholic Steatohepatitis in Mice
por: Teratani, Toshiaki, et al.
Publicado: (2019)

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
por: Komiya, Chikara, et al.
Publicado: (2017)

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
por: Brennan, Paul N., et al.
Publicado: (2023)

Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway
por: Zhou, Ling, et al.
Publicado: (2017)

Compound Biejia-Ruangan tablet as an adjunctive therapy to entecavir for chronic hepatitis B complicated with hepatic fibrosis: A systematic review and meta-analysis of randomized controlled trials
por: Xu, Yong-hong, et al.
Publicado: (2022)

Experimental study on effect of Compound Biejia Ruangan prescription on high-resolution computerized tomographic images in bleomycin induced pulmonary fibrosis rats
por: Dong-wei, Zhang, et al.
Publicado: (2003)

Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2020)

Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Rong, Guanghua, et al.
Publicado: (2020)

Salacia chinensis L. Stem Extract Exerts Antifibrotic Effects on Human Hepatic Stellate Cells through the Inhibition of the TGF-β1-Induced SMAD2/3 Signaling Pathway
por: Phaosri, Mattareeyapar, et al.
Publicado: (2019)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway
por: Zhang, Jie, et al.
Publicado: (2021)

Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial
por: Qu, Jianhui, et al.
Publicado: (2014)

Huangjia Ruangan Granule Inhibits Inflammation in a Rat Model with Liver Fibrosis by Regulating TNF/MAPK and NF-κB Signaling Pathways
por: Cai, Qiang, et al.
Publicado: (2022)

Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis
por: Ebrahimpour, Afshin, et al.
Publicado: (2022)

Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma
por: Chen, Cuilan, et al.
Publicado: (2022)

Targeting Endothelial Necroptosis Disrupts Profibrotic Endothelial–Hepatic Stellate Cells Crosstalk to Alleviate Liver Fibrosis in Nonalcoholic Steatohepatitis
por: Yan, Mengli, et al.
Publicado: (2023)

The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
por: Liu, Boqiang, et al.
Publicado: (2022)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
por: Maher, Toby M., et al.
Publicado: (2019)

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_um7rtmnifvqj47pcrs8uq6nann